TP53 and neoplasm: Our research elucidates a previously unknown mechanism by which the enrichment of lipid droplets and the Cyb5r3 molecule anchor the p53/Myh9 complex to these droplets, thereby facilitating MDM2 binding and accelerating p53 degradation within tumor cells.